 |
인쇄하기
취소
|
CJ announces license agreement with Helsinn
CJ CheilJedang said last Monday that it has signed a license agreement with Switzerland based Helsinn Healthcare SA for Helsinn’s new product for potential use in the prevention of chemotherapy-induced nausea and vomiting (CINV).
According to CJ officials, the agreement covers the exclusive license and distribution rights for a combination antiemetic agent (in both oral and intravenous forms...
According to CJ officials, the agreement covers the exclusive license and distribution rights for a combination antiemetic agent (in both oral and intravenous forms...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.